120
Participants
Start Date
November 22, 2020
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Apixaban
From postoperative day 3, patients will receive oral Apixaban 2.5mg bid for six months.
Warfarin
From postoperative day 3, patients will receive oral Warfarin 2.5mg qd with titration of dose to maintain a target INR of 2-3 for six months.
Aspirin
From postoperative day 3, patients will receive oral Aspirin Enterie Ccoated Tablets 100mg qd for six months.
Dipyridamole
From postoperative day 3, patients will receive oral dipyridamole 25mg tid for three months.
Low molecular weight heparin
From postoperative day 3, patients will receive subcutaneous injection of Low Molecular Weight Heparin (4100 IU) once daily for first five days.
Clinical Medical College of Yangzhou University, Yangzhou
Northern Jiangsu People's Hospital
OTHER